Translation Therapeutics
Translational Therapeutics Inc. is an IND-ready pharmaceutical company located in the Boston metropolitan area, dedicated to developing innovative therapeutics and diagnostics for cancers caused by the oncogene eIF4E. With a focus on addressing the unmet medical needs of 4E cancers, which account for 25% of all cancer cases in the U.S., the company aims to provide safe and effective targeted treatments.
The company's lead therapeutic agent targets a critical function in the cancer process, effectively closing the "gate" that allows cancer to progress. Currently, Translational Therapeutics has established its regulatory strategy and manufacturing pipeline, preparing to initiate a Phase III clinical trial to confirm the efficacy of its therapeutic system in an orphan indication.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.